'Numerous' Substances That May Slow Aging Discovered With New AI Tool

Full Article
'Numerous' Substances That May Slow Aging Discovered With New AI Tool

The AI platform AgeXtend has made significant strides in identifying substances that could potentially slow aging and enhance health. Developed by researchers at IIIT-Delhi, this innovative tool screened over 1.1 billion compounds, marking a pivotal advancement in longevity research. The findings, published in Nature Aging, showcase the platform's capability to predict and validate compounds with geroprotective effects.

AgeXtend's applications extend beyond mere discovery; it serves as a 'discovery engine' for anti-aging research, opening avenues for personalized medicine and drug development. The integration of AI in analyzing biomarkers and aging clocks allows researchers to target the fundamental causes of aging rather than just treating age-related diseases. While the initial results are promising, further testing and regulatory approval are essential before these compounds can be utilized therapeutically.

• AgeXtend screens over 1.1 billion compounds for anti-aging potential.

• AI-driven approaches are crucial for extending human healthy lifespan.

Key AI Terms Mentioned in this Article

Geroprotective Effects

Geroprotective effects refer to substances that can extend lifespan or combat age-related decline.

Biomarkers

Biomarkers are biological indicators used to assess health or disease, crucial for aging research.

Aging Clocks

Aging clocks estimate biological age, helping researchers understand aging processes more accurately.

Companies Mentioned in this Article

IIIT-Delhi

IIIT-Delhi is a research institute that developed AgeXtend, focusing on AI applications in longevity.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 4month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 4month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 4month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 4month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics